(Q36514338)

14 August 2017

1 reference

title

Outlook: who needs LH in ovarian stimulation? (English)

1 reference

14 August 2017

Alviggi C

1

1 reference

14 August 2017

Clarizia R

2

1 reference

14 August 2017

Mollo A

3

1 reference

14 August 2017

Ranieri A

4

1 reference

14 August 2017

De Placido G

5

1 reference

14 August 2017

publication date

1 May 2006

1 reference

Reproductive BioMedicine Online

14 August 2017

published in

1 reference

14 August 2017

volume

12

1 reference

14 August 2017

issue

5

1 reference

14 August 2017

page(s)

599-607

1 reference

Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized cont

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Recombinant follicle stimulating hormone is effective in poor responders to highly purified follicle stimulating hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

FSH induction of functional LH receptors in granulosa cells cultured in a chemically defined medium

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Current concepts and novel applications of LH activity in ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

What clinical evidence for an LH ceiling?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Intracytoplasmic sperm injection pregnancy after low-dose human chorionic gonadotropin alone to support ovarian folliculogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Follicular oestrogen synthesis: the 'two-cell, two-gonadotrophin' model revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Insulin-like growth factor-I gene expression in human granulosa-lutein cells

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Mutations and polymorphisms in gonadotropin genes

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Inhibins, activins, and follistatin in the aging female and male

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

A common polymorphic allele of the human luteinizing hormone beta-subunit gene: additional mutations and differential function of the promoter sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

The luteinizing hormone surge--the final stage in ovulation induction: modern aspects of ovulation triggering.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Gonadotropins and gonadotropin receptors during the perimenopause.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

The Role of Gonadotropins in the Selection of the Preovulatory Follicle

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Anatomy of the human ovarian insulin-like growth factor system

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961186-8

7 January 2021

Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003973

Identifiers

DOI

10.1016/S1472-6483(10)61186-8

1 reference

14 August 2017

1 reference